栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/04 | 1,594 | 1,601 | 1,581 | 1,592 | +2 | +0.1% | 78,300 |
2023/04/03 | 1,581 | 1,595 | 1,570 | 1,590 | +27 | +1.7% | 123,100 |
2023/03/31 | 1,568 | 1,570 | 1,552 | 1,563 | +2 | +0.1% | 71,200 |
2023/03/30 | 1,566 | 1,571 | 1,555 | 1,561 | -23 | -1.5% | 63,400 |
2023/03/29 | 1,557 | 1,586 | 1,550 | 1,584 | +32 | +2.1% | 137,800 |
2023/03/28 | 1,568 | 1,574 | 1,550 | 1,552 | -11 | -0.7% | 54,100 |
2023/03/27 | 1,565 | 1,572 | 1,561 | 1,563 | +8 | +0.5% | 70,200 |
2023/03/24 | 1,548 | 1,561 | 1,540 | 1,555 | +4 | +0.3% | 53,500 |
2023/03/23 | 1,550 | 1,551 | 1,534 | 1,551 | -9 | -0.6% | 93,800 |
2023/03/22 | 1,580 | 1,583 | 1,560 | 1,560 | ±0 | ±0% | 76,800 |
2023/03/20 | 1,591 | 1,594 | 1,560 | 1,560 | -46 | -2.9% | 73,100 |
2023/03/17 | 1,608 | 1,612 | 1,593 | 1,606 | +12 | +0.8% | 104,900 |
2023/03/16 | 1,561 | 1,595 | 1,561 | 1,594 | +1 | +0.1% | 102,100 |
2023/03/15 | 1,597 | 1,600 | 1,587 | 1,593 | +10 | +0.6% | 84,200 |
2023/03/14 | 1,583 | 1,594 | 1,566 | 1,583 | -18 | -1.1% | 129,400 |
2023/03/13 | 1,608 | 1,610 | 1,594 | 1,601 | -24 | -1.5% | 65,400 |
2023/03/10 | 1,617 | 1,634 | 1,615 | 1,625 | -11 | -0.7% | 93,100 |
2023/03/09 | 1,625 | 1,636 | 1,617 | 1,636 | +20 | +1.2% | 83,100 |
2023/03/08 | 1,620 | 1,627 | 1,615 | 1,616 | -7 | -0.4% | 107,100 |
2023/03/07 | 1,610 | 1,631 | 1,608 | 1,623 | +18 | +1.1% | 114,100 |
2023/03/06 | 1,598 | 1,606 | 1,589 | 1,605 | +16 | +1% | 107,000 |
2023/03/03 | 1,591 | 1,591 | 1,577 | 1,589 | +10 | +0.6% | 94,400 |
2023/03/02 | 1,576 | 1,589 | 1,571 | 1,579 | +5 | +0.3% | 83,700 |
2023/03/01 | 1,563 | 1,574 | 1,563 | 1,574 | +13 | +0.8% | 103,100 |
2023/02/28 | 1,571 | 1,574 | 1,560 | 1,561 | -1 | -0.1% | 99,300 |
2023/02/27 | 1,570 | 1,574 | 1,559 | 1,562 | -7 | -0.4% | 36,000 |
2023/02/24 | 1,558 | 1,573 | 1,550 | 1,569 | +9 | +0.6% | 86,300 |
2023/02/22 | 1,560 | 1,567 | 1,552 | 1,560 | -9 | -0.6% | 113,500 |
2023/02/21 | 1,566 | 1,576 | 1,564 | 1,569 | +3 | +0.2% | 71,700 |
2023/02/20 | 1,563 | 1,577 | 1,563 | 1,566 | +3 | +0.2% | 40,500 |
2023/02/17 | 1,562 | 1,571 | 1,560 | 1,563 | -8 | -0.5% | 62,800 |
2023/02/16 | 1,575 | 1,580 | 1,570 | 1,571 | +9 | +0.6% | 42,600 |
2023/02/15 | 1,568 | 1,573 | 1,556 | 1,562 | -3 | -0.2% | 87,900 |
2023/02/14 | 1,579 | 1,589 | 1,559 | 1,565 | +7 | +0.4% | 56,900 |
2023/02/13 | 1,565 | 1,567 | 1,545 | 1,558 | -1 | -0.1% | 71,400 |
2023/02/10 | 1,566 | 1,579 | 1,557 | 1,559 | -18 | -1.1% | 80,300 |
2023/02/09 | 1,559 | 1,577 | 1,554 | 1,577 | +9 | +0.6% | 70,100 |
2023/02/08 | 1,576 | 1,576 | 1,562 | 1,568 | +10 | +0.6% | 72,800 |
2023/02/07 | 1,571 | 1,572 | 1,556 | 1,558 | -18 | -1.1% | 87,700 |
2023/02/06 | 1,600 | 1,600 | 1,575 | 1,576 | -9 | -0.6% | 79,900 |
2023/02/03 | 1,581 | 1,585 | 1,573 | 1,585 | -4 | -0.3% | 114,900 |
2023/02/02 | 1,607 | 1,607 | 1,580 | 1,589 | -19 | -1.2% | 201,400 |
2023/02/01 | 1,600 | 1,614 | 1,582 | 1,608 | +20 | +1.3% | 199,600 |
2023/01/31 | 1,602 | 1,615 | 1,581 | 1,588 | -44 | -2.7% | 335,700 |
2023/01/30 | 1,650 | 1,657 | 1,630 | 1,632 | -10 | -0.6% | 189,800 |
2023/01/27 | 1,670 | 1,673 | 1,635 | 1,642 | -25 | -1.5% | 144,500 |
2023/01/26 | 1,668 | 1,668 | 1,653 | 1,667 | +9 | +0.5% | 135,200 |
2023/01/25 | 1,653 | 1,669 | 1,642 | 1,658 | +6 | +0.4% | 133,500 |
2023/01/24 | 1,632 | 1,654 | 1,621 | 1,652 | +28 | +1.7% | 115,100 |
2023/01/23 | 1,619 | 1,624 | 1,603 | 1,624 | +25 | +1.6% | 102,300 |
501~
550
件表示中 / 6937件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 225,300円 | +0.4% | -8.4% | 2.35% | 28.92倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
持田薬 | 306,500円 | +3.0% | +27.5% | 2.61% | 19.40倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 85,000円 | +22.8% | - | 0.00% | 69.44倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
あすかHD | 237,600円 | +0.3% | +2.7% | 2.10% | 13.48倍 | 1.05倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム